258 reports of this reaction
11.9% of all AVOBENZONE, OCTISALATE, AND OCTOCRYLENE reports
#2 most reported adverse reaction
ACNE is the #2 most commonly reported adverse reaction for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, manufactured by Alchemee, LLC. There are 258 FDA adverse event reports linking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE to ACNE. This represents approximately 11.9% of all 2,163 adverse event reports for this drug.
Patients taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE who experience acne should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACNE is a frequently reported adverse event for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, accounting for a significant proportion of all reports.
In addition to acne, the following adverse reactions have been reported for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE:
The following drugs have also been linked to acne in FDA adverse event reports:
ACNE has been reported as an adverse event in 258 FDA reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACNE accounts for approximately 11.9% of all adverse event reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, making it one of the most commonly reported side effect.
If you experience acne while taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.